Sanofi's Voting Rights and Shares: An Overview
Sanofi has recently provided vital information regarding its total number of voting rights and shares. This disclosure is essential for investors and stakeholders wanting to understand the company’s governance and market position. The data shared is regulated by specific financial laws in France, ensuring transparency and accountability.
Company Profile
Sanofi, a notable French société anonyme, holds a registered share capital of €2,452,461,656. The company is headquartered at 46, avenue de la Grande Armée, 75017 Paris, and is officially registered with the Paris Commercial and Companies Registry under the number 395 030 844. Such information not only underscores the company’s legitimacy but also reinforces investor confidence.
Total Shares Issued and Voting Rights
As of June 30, 2025, Sanofi has issued a total of 1,227,756,274 shares. Understanding the distribution of these shares is crucial for shareholders and potential investors alike. Additionally, the number of real voting rights, which excludes treasury shares, stands at 1,351,296,496. This indicates a significant level of active voting participation within the company.
Theoretical Voting Rights
In regard to all issued shares, including treasury shares, the theoretical number of voting rights totals 1,361,952,562. This information can guide investors in evaluating Sanofi’s shareholder structure and governance. Such transparency facilitates informed decision-making for those interested in the company’s performance.
Importance of Regulated Information
These updates are mandated by Article L. 233-8 II of the French Commercial Code and Article 223-16 of the Regulation of the French stock market authority. By adhering to these regulations, Sanofi confirms its commitment to providing shareholders with accurate and timely information regarding their rights and the company’s capital structure.
Accessing Further Information
For those wishing to explore more extensive details, the information is available online on Sanofi’s investor relations site under the section dedicated to regulated information in France. This practice ensures that all stakeholders have access to vital data that could impact their investment decisions.
Contacting Sanofi
For any queries regarding shareholding or voting rights, investors can reach out to Sanofi’s Investor Relations Department via email at investor.relations@sanofi.com. They are equipped to provide assistance and further clarify any concerns regarding the company’s shares and voting rights.
Frequently Asked Questions
What is the total number of shares issued by Sanofi?
As of June 30, 2025, Sanofi has issued a total of 1,227,756,274 shares.
How many voting rights does Sanofi have excluding treasury shares?
The number of real voting rights excluding treasury shares is 1,351,296,496.
What are the theoretical voting rights of Sanofi?
The theoretical number of voting rights including treasury shares is 1,361,952,562.
Where can I find more information about Sanofi's shares?
More information can be found on Sanofi's investor relations website under the section for regulated information.
Who can I contact for inquiries regarding Sanofi's shares?
For inquiries, you can contact Sanofi's Investor Relations Department at the following email: investor.relations@sanofi.com.
